Eddie L. Imada
-
- SARS-CoV-2 and COVID-19 Research 2
- COVID-19 Clinical Research Studies 2
-
- Prostate Cancer Treatment and Research 3
- Renal cell carcinoma treatment 2
- Prostate Cancer Diagnosis and Treatment 2
-
- Neurofibromatosis and Schwannoma Cases 3
-
- Acute Myeloid Leukemia Research 2
-
- RNA modifications and cancer 2
- Co-authors
- Luigi MarchionniClaudio ZanettiniMohamed OmarElizabeth ColantuoniBen LangmeadGiovanni ParmigianiElisete Pains RodriguesChristopher Wilks
- Cited by
- Cancer ResearchOncologyImmunology
- Partner nations
- United StatesBrazilItaly
In The Last Decade
Eddie L. Imada
19 papers receiving 376 citations
Peers
Comparison fields: 5 of 77
- Cancer Research 65
- Oncology 78
- Immunology 60
- Modeling and Simulation 13
- Infectious Diseases 46
Countries citing papers authored by Eddie L. Imada
This map shows the geographic impact of Eddie L. Imada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eddie L. Imada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eddie L. Imada more than expected).
Fields of papers citing papers by Eddie L. Imada
This network shows the impact of papers produced by Eddie L. Imada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eddie L. Imada. The network helps show where Eddie L. Imada may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eddie L. Imada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2023 | 5 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 2 | |
| 7 | 2022 | 4 | |
| 8 | 2022 | 1 | |
| 9 | 2022 | 3 | |
| 10 | 2021 | 65 | |
| 11 | 2021 | 22 | |
| 12 | 2021 | 114 | |
| 13 | 2021 | 60 | |
| 14 | 2021 | 1 | |
| 15 | 2020 | 7 | |
| 16 | 2020 | 9 | |
| 17 | 2019 | 13 | |
| 18 | 2019 | 14 | |
| 19 | 2016 | 16 | |
| 20 | 2016 | 35 |
About Eddie L. Imada
Eddie L. Imada is a scholar working on Transplantation, Cancer Research and Modeling and Simulation, having authored 21 papers that have together received 378 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (3 papers), Neurofibromatosis and Schwannoma Cases (3 papers), Acute Myeloid Leukemia Research (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Renal cell carcinoma treatment (2 papers), COVID-19 Clinical Research Studies (2 papers), RNA modifications and cancer (2 papers) and Prostate Cancer Diagnosis and Treatment (2 papers). The work is most often cited by research in Cancer Research (65 citations), Oncology (78 citations) and Immunology (60 citations). Eddie L. Imada has collaborated with scholars based in United States, Brazil and Italy. Frequent co-authors include Luigi Marchionni, Claudio Zanettini, Mohamed Omar, Elizabeth Colantuoni, Ben Langmead, Giovanni Parmigiani, Elisete Pains Rodrigues, Christopher Wilks, André Luíz Martinez de Oliveira and Brad Solomon.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.